Press Releases

06 January 2009
Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human
Primates at February Keystone Conference

06 October 2008
Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.

15 September 2008
Cequent Pharmaceuticals Meets Novartis Option Milestone

05 May 2008
Cequent Names Mike D. Taylor, PhD to Board of Directors

18 June 2007
Cequent Pharmaceuticals Completes $9 Million Series A Financing with Equity Investment from Novartis Option Fund

14 June 2007
Cequent Pharmaceuticals expands Scientific Leadership Team with Key Hires

02 May 2007
Cequent Pharmaceuticals tkRNAi Technology to be Presented at the RNAi-2007-Boston Meeting: RNA Interference: Biochemistry to Drugs & Therapeutics

13 April 2007
Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the American Association of Cancer Research Annual Meeting in Los Angeles

15 February 2007

Cequent Pharmaceuticals, Inc. to Present February 27 at the Molecular Medicine Tri-Conference in San Francisco, CA.